These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11747781)

  • 1. [Some considerations on the Consensus of the Spanish Diabetes Society and the Spanish Society of Family and Community Medicine on the criteria and guidelines for combined therapy for type 2 diabetes].
    González-Clemente JM; Giménez-Pérez G; Caixàs A; Mauricio D
    Aten Primaria; 2001 Nov; 28(9):624-5. PubMed ID: 11747781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetes. How can the infarction risk be reduced?].
    MMW Fortschr Med; 2002 Feb; 144(9):51. PubMed ID: 11921655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain beginning of insulin therapy: yes, we can, but...].
    Rohrer A
    Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late diagnosis. Only after infarct is diabetes detected].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035427
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effectiveness in type 2 diabetes prevention: a forced landing to reality].
    Costa B
    Med Clin (Barc); 2008 Mar; 130(8):295-7. PubMed ID: 18358121
    [No Abstract]   [Full Text] [Related]  

  • 7. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.
    Derosa G; Salvadeo SA; D'Angelo A; Ferrari I; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    Curr Med Res Opin; 2009 Mar; 25(3):607-15. PubMed ID: 19232035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The rehabilitation of metformin].
    Fernández Fernández I
    Aten Primaria; 2005 Sep; 36(4):192-3. PubMed ID: 16153371
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Type 2 diabetes -- higher doses of metformin improve metabolic control].
    Rosak C; Hövelmann R; Martin J
    MMW Fortschr Med; 2003 May; 145(21):39. PubMed ID: 12845866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acarbose for the treatment of impared glucose tolerance?].
    Carracedo E
    Gac Sanit; 2005; 19(3):265; author reply 265-6. PubMed ID: 15960964
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary disease -- risk factors to be controlled aggressively. Sweet hearts of women are especially endangered].
    MMW Fortschr Med; 2003 Jun; 145(24):51. PubMed ID: 12866302
    [No Abstract]   [Full Text] [Related]  

  • 18. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of glimepiride combined with other drugs in the treatment of diabetes.
    Liu X; Zeng L; Xu W
    Pak J Pharm Sci; 2018 May; 31(3(Special)):1103-1107. PubMed ID: 29735458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: the past, presence, and future.
    Alušík Š; Paluch Z
    Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.